Northern Trust’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.9K | Sell |
38,127
-78,780
| -67% | -$63.8K | ﹤0.01% | 4303 |
|
|
2025
Q1 | $89.8K | Buy |
116,907
+33,520
| +40% | +$25.7K | ﹤0.01% | 4141 |
|
|
2024
Q4 | $106K | Sell |
83,387
-22,990
| -22% | -$29.3K | ﹤0.01% | 4144 |
|
|
2024
Q3 | $220K | Sell |
106,377
-18,309
| -15% | -$37.9K | ﹤0.01% | 3855 |
|
|
2024
Q2 | $475K | Buy |
124,686
+2,539
| +2% | +$9.67K | ﹤0.01% | 3535 |
|
|
2024
Q1 | $579K | Buy |
122,147
+8,050
| +7% | +$38.2K | ﹤0.01% | 3516 |
|
|
2023
Q4 | $487K | Sell |
114,097
-1,421
| -1% | -$6.07K | ﹤0.01% | 3545 |
|
|
2023
Q3 | $357K | Buy |
115,518
+33,923
| +42% | +$105K | ﹤0.01% | 3611 |
|
|
2023
Q2 | $367K | Buy |
81,595
+60,428
| +285% | +$272K | ﹤0.01% | 3620 |
|
|
2023
Q1 | $121K | Hold |
21,167
| – | – | ﹤0.01% | 4035 |
|
|
2022
Q4 | $128K | Hold |
21,167
| – | – | ﹤0.01% | 4014 |
|
|
2022
Q3 | $140K | Hold |
21,167
| – | – | ﹤0.01% | 4010 |
|
|
2022
Q2 | $110K | Sell |
21,167
-80,739
| -79% | -$420K | ﹤0.01% | 4138 |
|
|
2022
Q1 | $703K | Sell |
101,906
-5,278
| -5% | -$36.4K | ﹤0.01% | 3597 |
|
|
2021
Q4 | $1.34M | Buy |
107,184
+759
| +0.7% | +$9.45K | ﹤0.01% | 3427 |
|
|
2021
Q3 | $3.33M | Sell |
106,425
-12,252
| -10% | -$383K | ﹤0.01% | 3001 |
|
|
2021
Q2 | $3.4M | Buy |
118,677
+3,178
| +3% | +$91K | ﹤0.01% | 3069 |
|
|
2021
Q1 | $5.01M | Buy |
115,499
+476
| +0.4% | +$20.6K | ﹤0.01% | 2737 |
|
|
2020
Q4 | $8.23M | Buy |
+115,023
| New | +$8.23M | ﹤0.01% | 2377 |
|